Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

JCO precision oncology

Showing results (1-10 of 2,015) with videos related to

Pageof 202
Sort By:
JCO Precision Oncology|January 9, 2025
Addressing Bias in Feature Importance: A Hybrid Approach for Risk Prediction in Prognostic Survival ModelsYoshiyasu Takefuji
JCO Precision Oncology|February 12, 2025
<i>ALK</i>-Rearranged Non-Small Cell Lung Cancer Presenting as a Large Mediastinal Mass: A Case ReportUrs M Weber, Lawrence Einhorn, Paul A Bunn
JCO Precision Oncology|November 20, 2024
New Molecular Targets in Prostate Cancer-The Emerging Role of <i>ACP1</i> and Low Molecular Weight Protein Tyrosine PhosphataseMiguel Zugman, Alexander Chehrazi-Raffle, Oren Smaletz
JCO Precision Oncology|November 22, 2024
Lethal 5-Fluorouracil Toxicity in a Carrier of <i>DPYD</i> c.704G>A (p.R235Q)Brianna M Bembenek, Aneena Joshy, Steven M Offer
JCO Precision Oncology|December 5, 2024
Clinical and Radiographic Benefit of a Patient With Metastatic Non-Small Cell Lung Cancer Harboring an <i>EGFR::ERBB4</i> Fusion Through Use of EGFR Tyrosine Kinase InhibitorsAmy Guimaraes-Young, Kurtis D Davies, Patricia Trevisan, et al.
JCO Precision Oncology|February 28, 2025
Real-Time Monitoring in Renal Cell Carcinoma With Circulating Tumor DNA: A Step Forward, But How Far?Zeynep B Zengin, Ritesh R Kotecha
JCO Precision Oncology|February 6, 2025
Precision-Guided Durable Response From Venetoclax With Decitabine in a Patient With a Metastatic Refractory <i>IDH2</i>-Mutant CholangiocarcinomaEylül Özgü, Ünal Metin Tokat, Ashkan Adibi, et al.
JCO Precision Oncology|June 7, 2023
Effect of Intertumoral Biomarker Heterogeneity on the Reliability of Biomarker Assays in Colorectal Cancer: Call for a New ApproachMamoun Younes
JCO Precision Oncology|October 14, 2022
State of the Biomarker Science in Ovarian Cancer: A National Cancer Institute Clinical Trials Planning Meeting ReportJosee-Lyne Ethier, Katherine C Fuh, Rebecca Arend, et al.
JCO Precision Oncology|November 4, 2022
Exquisitely Platinum-Sensitive Triple-Negative Breast Cancer, Time for <i>BRCA</i> Methylation Testing?Tira J Tan, J Lynn Fink, Timothy K Tay, et al.
Pageof 202

Showing results (1-10 of 2,015) with videos related to

Sort By:
Pageof 202
JCO Precision Oncology|January 9, 2025
Addressing Bias in Feature Importance: A Hybrid Approach for Risk Prediction in Prognostic Survival ModelsYoshiyasu Takefuji
JCO Precision Oncology|February 12, 2025
<i>ALK</i>-Rearranged Non-Small Cell Lung Cancer Presenting as a Large Mediastinal Mass: A Case ReportUrs M Weber, Lawrence Einhorn, Paul A Bunn
JCO Precision Oncology|November 20, 2024
New Molecular Targets in Prostate Cancer-The Emerging Role of <i>ACP1</i> and Low Molecular Weight Protein Tyrosine PhosphataseMiguel Zugman, Alexander Chehrazi-Raffle, Oren Smaletz
JCO Precision Oncology|November 22, 2024
Lethal 5-Fluorouracil Toxicity in a Carrier of <i>DPYD</i> c.704G>A (p.R235Q)Brianna M Bembenek, Aneena Joshy, Steven M Offer
JCO Precision Oncology|December 5, 2024
Clinical and Radiographic Benefit of a Patient With Metastatic Non-Small Cell Lung Cancer Harboring an <i>EGFR::ERBB4</i> Fusion Through Use of EGFR Tyrosine Kinase InhibitorsAmy Guimaraes-Young, Kurtis D Davies, Patricia Trevisan, et al.
JCO Precision Oncology|February 28, 2025
Real-Time Monitoring in Renal Cell Carcinoma With Circulating Tumor DNA: A Step Forward, But How Far?Zeynep B Zengin, Ritesh R Kotecha
JCO Precision Oncology|February 6, 2025
Precision-Guided Durable Response From Venetoclax With Decitabine in a Patient With a Metastatic Refractory <i>IDH2</i>-Mutant CholangiocarcinomaEylül Özgü, Ünal Metin Tokat, Ashkan Adibi, et al.
JCO Precision Oncology|June 7, 2023
Effect of Intertumoral Biomarker Heterogeneity on the Reliability of Biomarker Assays in Colorectal Cancer: Call for a New ApproachMamoun Younes
JCO Precision Oncology|October 14, 2022
State of the Biomarker Science in Ovarian Cancer: A National Cancer Institute Clinical Trials Planning Meeting ReportJosee-Lyne Ethier, Katherine C Fuh, Rebecca Arend, et al.
JCO Precision Oncology|November 4, 2022
Exquisitely Platinum-Sensitive Triple-Negative Breast Cancer, Time for <i>BRCA</i> Methylation Testing?Tira J Tan, J Lynn Fink, Timothy K Tay, et al.
Pageof 202